Oncotarget,
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
Watch this #OncotargetShort video of a trending research paper on LP-184 retaining potency in refractory lung cancer by…
On #SoundCloud: Dr. Aditya Kulkarni discusses a research paper he co-authored: "The acylfulvene alkylating agent, LP-184…
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
On #Soundcloud: Listen to a blog summary of a trending 2021 paper: "The acylfulvene alkylating agent, LP-184, retains nanomolar…
Watch this #OncotargetShort video of a trending research paper on LP-184 retaining potency in refractory lung cancer by…
#TrendingWithImpact: This year, Lantern Pharma
Watch this #OncotargetShort video of a trending research paper on LP-184 retaining potency in refractory lung cancer by…
#TrendingWithImpact: This year, Lantern Pharma
#TrendingWithImpact: Today's #trending Oncotarget #paper: "The acylfulvene alkylating agent, LP-184, retains nanomolar potency…
Watch: #author #interview with Dr. Aditya Kulkarni on a recent paper published by Oncotarget: "The acylfulvene alkylating agent…
#TrendingWithImpact: This year, @LanternPharma
Watch an #OncotargetShort video about a trending research paper. LP-184 retains potency in refractory lung cancer by…
Watch: #OncotargetShort video of a trending paper, entitled, "The acylfulvene alkylating agent, LP-184, retains nanomolar…
#TrendingWithImpact: This year, Lantern Pharma
Research paper: "The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying…
Research Paper: "The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying…